KRAS and cancer: Seth et al. reported that inactivation of LDHA in oncogenic K‐RAS or EGFR NSCLC mouse models led to reduced tumorigenesis and disease regression and showed that LDHA is essential for cancer‐initiating cell survival and proliferation using an LDHA‐specific small molecule inhibitor.30